NEW YORK (GenomeWeb News) – Coda Genomics today announced that it has changed its name to Verdezyne.
 
The Laguna Hills, Calif.-based firm uses computational methods to design and synthesize gene libraries for engineering proteins, metabolic pathways, and microorganisms. Its technologies are used to optimize commercial fermentation processes, which are applied to manufacturing platform chemicals and biofuels.
 
The company was founded in 2005 and is privately held.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.